| NHNKY Stock | | | USD 13.14 1.42 9.75% |
President
Mr. Hirokazu Ogino was serving as Executive President and Representative Director in NIHON KOHDEN CORPORATION since June 28, 2017. He joined the Company in April 1995. His previous titles include Director of Marketing Strategy, Chief Director of Overseas Business, Executive Officer, Senior Executive Officer, Managing Executive Officer, Chief Operating Officer and President in the Company. He used to work for two subsidiaries, including Nihon Kohden Europe GmbH and Nihon Kohden America, Inc. since 2017.
| Age | 53 |
| Tenure | 7 years |
| Phone | 81 3 5996 8000 |
| Web | https://www.nihonkohden.com |
Nihon Kohden Management Efficiency
The company has return on total asset
(ROA) of
0.0598 % which means that it generated a profit of $0.0598 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0988 %, meaning that it generated $0.0988 on every $100 dollars invested by stockholders. Nihon Kohden's management efficiency ratios could be used to measure how well Nihon Kohden manages its routine affairs as well as how well it operates its assets and liabilities.
Nihon Kohden Corp has accumulated 325
M in total debt with debt to equity ratio
(D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. Nihon Kohden Corp has a current ratio of 3.66, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Nihon Kohden until it has trouble settling it off, either with new capital or with free cash flow. So, Nihon Kohden's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nihon Kohden Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nihon to invest in growth at high rates of return. When we think about Nihon Kohden's use of debt, we should always consider it together with cash and equity.
Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan. Nihon Kohden operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 56 people. Nihon Kohden Corp [NHNKY] is a
Pink Sheet which is traded between brokers as part of OTC trading.
Management Performance
Nihon Kohden Corp Leadership Team
Elected by the shareholders, the Nihon Kohden's board of directors comprises two types of representatives: Nihon Kohden inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nihon. The board's role is to monitor Nihon Kohden's management team and ensure that shareholders' interests are well served. Nihon Kohden's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nihon Kohden's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yasuhiro Yoshitake, Executive Officer, Chief Senior Director of Asia & Near and Middle East | |
| Hirokazu Ogino, President, COO, General Manager of Marketing Strategy Department and Representative Director | |
| Takashi Tamura, Senior Executive Officer, Chief Director of Service Business, Director | |
| Eiichi Tanaka, Senior Executive Officer | |
| Eri Watanabe, Deputy Officer | |
| Natsumi Kajiyama, Corp Department | |
| Kenji Furukawa, Executive Officer, Director of Human Resources, Director of Phoenix Academy | |
| Tadashi Hasegawa, Managing Executive Officer, Director | |
| Fumio Hirose, Senior Executive Officer, Chief Director of Respiratory Organs & Anesthesia Apparatus Business | |
| Hiroyuki Satake, Executive Officer, Chief Director of Medical Devices Business | |
Nihon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nihon Kohden a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Nihon Pink Sheet Analysis
When running Nihon Kohden's price analysis, check to
measure Nihon Kohden's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nihon Kohden is operating at the current time. Most of Nihon Kohden's value examination focuses on studying past and present price action to
predict the probability of Nihon Kohden's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nihon Kohden's price. Additionally, you may evaluate how the addition of Nihon Kohden to your portfolios can decrease your overall portfolio volatility.